SharesGrow.com S&P 및 Nasdaq 내재가치 문의하기

हिन्दी

← 전체 종목으로

Phathom Pharmaceuticals, Inc. PHAT NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Analyst Price Target

Phathom Pharmaceuticals, Inc. (PHAT) 에는 12 개의 동종 기업 이 비교 대상으로 식별되었습니다 Healthcare 섹터. 동종 기업에는 ABOS, AMLX, AVRO, BPMC, CGEM, CNSP 등이 있습니다.

PHAT 의 시가총액은 $1.01B, 동종 기업 평균 시가총액과 비교하여 $1.42B.

동종·유사 기업 — PHAT

Acumen Pharmaceuticals, Inc.

$2.72 +1.49% $164.76M

Amylyx Pharmaceuticals, Inc.

$17.12 +1.18% $1.42B

$1.40 -1.41% $5.24M

Blueprint Medicines Corporation

$129.46 +0.14% $8.36B

Cullinan Oncology, Inc.

$14.95 +4.18% $904.87M

CNS Pharmaceuticals, Inc.

$2.75 +4.17% $1.58M

Day One Biopharmaceuticals, Inc.

$21.47 +0.05% $2.22B

Freeline Therapeutics Holdings plc

$6.49 +0.15% $28.28M

Structure Therapeutics Inc.

$54.25 +1.94% $3.12B

Hepion Pharmaceuticals, Inc.

$0.04 -19.58% $448.54K

Immix Biopharma, Inc.

$10.04 +1.93% $531.76M

Inozyme Pharma, Inc.

$4.00 +0.25% $258.25M

다른 사용자도 조회

Karuna Therapeutics, Inc.

Blueprint Medicines Corporation

Terns Pharmaceuticals, Inc.

Kiniksa Pharmaceuticals, Ltd.

Structure Therapeutics Inc.

Day One Biopharmaceuticals, Inc.

Amylyx Pharmaceuticals, Inc.

VectivBio Holding AG

문의하기

🎓

SharesGrow 아카데미

내재가치 계산법과 저평가 종목 찾기를 배우세요.

주간 라이브 세션

📧 [email protected]

📞 +65 8912 8000

메시지 보내기